Project

AFM-Telethon

Exploring the genetic and epigenetic background underlying phenotype’s variability in Emery Dreifuss Muscular Dystrophy

ITB Principal Investigator

Name

Exploring the genetic and epigenetic background underlying phenotype’s variability in Emery Dreifuss Muscular Dystrophy

Acronym

AFM-Telethon

Location

Segrate

Start Date

2022

End Date

2026

Funder

AFM-TELETHON

Partners

- National Institute of Molecular Genetics (INGM) “Romeo and Enrica Invernizzi” - "Sapienza" University of Rome, Rome, Italy (Prof. R. Rizzi - Institute of Applied Sciences and Intelligent Systems “Eduardo Caianiello” (ISASI), National Research Council (CNR), Napoli, Italy (Dr M. Mutarelli)

Emery Dreifuss Muscular Dystrophy (EDMD) is a rare genetic disease causing skeletal and cardiac muscles dysfunction. Multiple gene mutations have been described in patients, all of them involving some protein connected to the structure or function of the nuclear lamina. The nuclear lamina is important for controlling the DNA three-dimensional structure, a key player in the regulation of genome functionality. To date, despite the identification of genes responsible for EDMD it is difficult to create a clear connection between genotype (specific mutations on the DNA sequence) and the molecular mechanisms underlying the phenotypes (disease symptoms). We will use advanced experimental techniques, including methods that we developed, to understand the role of genetic and epigenetic background in specific tissues affected by EDMD dystrophy. This study will not only improve our basic knowledge of the disease but can lead to the identification of new targets for innovative therapies.
  • Pegoli G, et al. Role of Cdkn2a in the Emery-Dreifuss Muscular Dystrophy Cardiac Phenotype. Biomolecules (2021) 11(4):538. doi: 10.3390/biom11040538.
  • Bianchi A, et al. Dysfunctional polycomb transcriptional repression contributes to Lamin A/C dependent muscular dystrophy. J Clin Invest (2020) 130(5):2408-2421. doi: 10.1172/JCI128161.